Combinent Biomedical Systems
Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD6—9m (Dealroom.co estimates Dec 2010.)
Lexington Kentucky (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$3.0m | Series A | ||
$500k | Debt | ||
| N/A | $1.0m | Seed | |
| N/A | $750k | Debt | |
| N/A | $600k | Debt | |
| Total Funding | AUD6.2m | ||